Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. (Q48708921)

14 February 2018

title

Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. (English)

1 reference

14 February 2018

intraepithelial neoplasia

main subject

1 reference

Annelinde Terlou

1

1 reference

14 February 2018

Manon van Seters

2

1 reference

14 February 2018

Patricia C Ewing

3

1 reference

14 February 2018

Neil K Aaronson

4

1 reference

14 February 2018

Chad M Gundy

5

1 reference

14 February 2018

Claudia Heijmans-Antonissen

6

1 reference

14 February 2018

Wim G V Quint

7

1 reference

14 February 2018

Leen J Blok

8

1 reference

14 February 2018

Marc van Beurden

9

1 reference

14 February 2018

Theo J M Helmerhorst

10

1 reference

14 February 2018

language of work or name

English

0 references

publication date

15 January 2011

1 reference

14 February 2018

published in

Gynecologic Oncology

1 reference

14 February 2018

volume

121

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

157-162

1 reference

14 February 2018

Squamous vulvar intraepithelial neoplasia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Intraepithelial neoplasia of the vulva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Sexual function and somatopsychic reactions after local excision of vulvar intra‐epithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Use of the female sexual function index in women with vulvar intraepithelial neoplasia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Vulvar intraepithelial neoplasia: aspects of the natural history and outcome in 405 women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Treatment of vulvar intraepithelial neoplasia with topical imiquimod

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Topical imiquimod can reverse vulvar intraepithelial neoplasia: a randomised, double-blinded study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Imiquimod for treatment of vulvar and vaginal intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Vulvar intraepithelial neoplasia III: occult cancer and the impact of margin status on recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Immune responses to human papillomavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Immune control of human papillomavirus (HPV) associated anogenital disease and potential for vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Immune response modifiers--mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Imiquimod: mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.340

10.1016/J.YGYNO.2010.12.340

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

21239049

1 reference

14 February 2018